KIT:NICAMII

James Larkin1, Richard Marais2, Nuria Porta3

  • 1Skin and Renal Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK.

Cell reports. Medicine
|February 28, 2024
PubMed
概括

尼洛丁尼在罕见的带有KIT突变的粘膜和状黑色素瘤中表现出活性. 这种向治疗为患有这些难以治疗的黑色素瘤亚型的患者提供了新的治疗选择.